| Fecha | Hora | Fuente | Título | Símbolo | Compañía |
| 09/02/2018 | 08:13 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 05:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 14:27 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 14:24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 25/10/2017 | 05:04 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 17/10/2017 | 15:07 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 16/10/2017 | 16:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 13/10/2017 | 16:31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 13/10/2017 | 15:39 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 13/10/2017 | 15:24 | PR Newswire (US) | Consortium Led By GL Capital Completes Acquisition Of SciClone | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/10/2017 | 17:07 | PR Newswire (US) | NMI Holdings and Axcelis Technologies Set to Join S&P SmallCap 600 | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 15/09/2017 | 15:33 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 18/08/2017 | 16:20 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 17/08/2017 | 16:36 | PR Newswire (US) | SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/08/2017 | 15:05 | PR Newswire (US) | SciClone Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 09/08/2017 | 15:20 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 09/08/2017 | 15:05 | PR Newswire (US) | SciClone Reports Second Quarter 2017 Financial Results | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 02/08/2017 | 15:05 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (preliminary) (prem14a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 27/07/2017 | 16:15 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 08/06/2017 | 05:00 | PR Newswire (US) | SciClone Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/05/2017 | 15:12 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/05/2017 | 15:05 | PR Newswire (US) | SciClone Reports First Quarter 2017 Financial Results | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 04/05/2017 | 05:00 | PR Newswire (US) | SciClone Pharmaceuticals To Report First Quarter 2017 Financial Results On May 10, 2017 | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 28/04/2017 | 15:24 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 27/03/2017 | 05:00 | PR Newswire (US) | SciClone To Present At Needham Healthcare Conference On April 4, 2017 | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/03/2017 | 13:21 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 09/03/2017 | 15:13 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 09/03/2017 | 15:02 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 06/03/2017 | 05:00 | PR Newswire (US) | SciClone Reports 2016 Financial Results And 2017 Outlook | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 03/03/2017 | 15:05 | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |